Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study
Idiopathic REM sleep behaviour disorder (iRBD) is a powerful early sign of Parkinson’s
disease, dementia with Lewy bodies, and multiple system atrophy. This provides an …
disease, dementia with Lewy bodies, and multiple system atrophy. This provides an …
The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder
…, T Wicke, F Sixel‐Döring, A Janzen… - Movement …, 2018 - Wiley Online Library
Background Increasing evidence connects the gut microbiota and the onset and/or phenotype
of Parkinson's disease (PD). Differences in the abundances of specific bacterial taxa have …
of Parkinson's disease (PD). Differences in the abundances of specific bacterial taxa have …
Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder
Patients with isolated rapid-eye-movement sleep behaviour disorder (RBD) are commonly
regarded as being in the early stages of a progressive neurodegenerative disease involving α…
regarded as being in the early stages of a progressive neurodegenerative disease involving α…
[HTML][HTML] Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease
…, L Schulmeyer, D Vadasz, A Janzen… - Acta …, 2017 - Springer
Phosphorylated alpha-synuclein (p-alpha-syn) deposits, one of the neuropathological hallmarks
of Parkinson’s disease (PD), have recently been detected in dermal nerve fibres in PD …
of Parkinson’s disease (PD), have recently been detected in dermal nerve fibres in PD …
Progression of clinical markers in prodromal Parkinson's disease and dementia with Lewy bodies: a multicentre study
…, J Suescun, KA Woo, S Marelli, KE Martens, A Janzen… - Brain, 2023 - academic.oup.com
The neurodegenerative synucleinopathies, including Parkinson’s disease and dementia
with Lewy bodies, are characterized by a typically lengthy prodromal period of progressive …
with Lewy bodies, are characterized by a typically lengthy prodromal period of progressive …
Speech biomarkers in rapid eye movement sleep behavior disorder and Parkinson disease
…, S Marelli, PC Timm, LN Teigen, A Janzen… - Annals of …, 2021 - Wiley Online Library
Objective This multilanguage study used simple speech recording and high‐end pattern
analysis to provide sensitive and reliable noninvasive biomarkers of prodromal versus manifest …
analysis to provide sensitive and reliable noninvasive biomarkers of prodromal versus manifest …
[HTML][HTML] Genome-wide association study of REM sleep behavior disorder identifies polygenic risk and brain expression effects
Rapid-eye movement (REM) sleep behavior disorder (RBD), enactment of dreams during
REM sleep, is an early clinical symptom of alpha-synucleinopathies and defines a more …
REM sleep, is an early clinical symptom of alpha-synucleinopathies and defines a more …
The metabolic pattern of idiopathic REM sleep behavior disorder reflects early-stage Parkinson disease
SK Meles, RJ Renken, A Janzen… - Journal of Nuclear …, 2018 - Soc Nuclear Med
Idiopathic REM sleep behavior disorder (iRBD) is considered a prodromal stage of
Parkinson disease (PD) and other Lewy body disorders. Spatial covariance analysis of 18 F-FDG …
Parkinson disease (PD) and other Lewy body disorders. Spatial covariance analysis of 18 F-FDG …
Risk factors for phenoconversion in rapid eye movement sleep behavior disorder
…, M Terzaghi, M Miyamoto, A Janzen… - Annals of …, 2022 - Wiley Online Library
Objective This study was undertaken to follow up predictive factors for α‐synuclein–related
neurodegenerative diseases in a multicenter cohort of idiopathic/isolated rapid eye …
neurodegenerative diseases in a multicenter cohort of idiopathic/isolated rapid eye …
Neuronally derived extracellular vesicle α-synuclein as a serum biomarker for individuals at risk of developing Parkinson disease
IMPORTANCE Nonmotor symptoms of Parkinson disease (PD) often predate the movement
disorder by decades. Currently, there is no blood biomarker to define this prodromal phase. …
disorder by decades. Currently, there is no blood biomarker to define this prodromal phase. …